Please wait a minute...

中国现代手术学杂志  2017, Vol. 21 Issue (5): 398-400,0    DOI: 10.16260/j.cnki.1009-2188.2017.05.018
  临床论著 |
钻孔尿激酶注入引流联合阿托伐他汀钙治疗慢性硬膜下血肿的临床研究
张蕾1,侯梅英2,程刚3,国义民1
1. 衡水市第二人民医院神经外科,衡水 053000; 2. 衡水市第二人民医院医学影像科, 衡水 053000; 3. 衡水市第二人民医院泌尿外科,衡水 053000
Clinical Research of Urokinase Injection Following Punch Drainage Combined with Oral Atorvastatin Calcium in the Treatment of Chronic Subdural Hematoma
ZHANG Lei1, HOU Meiying2, CHENG Gang3, GUO Yimin1
1. Department of Neurosurgery, Hengshui Second People's Hospital, Hengshui 053000, Hebei, China; 2. Department of Imaging, Hengshui Second People's Hospital, Hengshui 053000, Hebei, China;3. Department of Urological Surgery, Hengshui Second People's Hospital, Hengshui 053000, Hebei, China
下载:  RICH HTML  PDF (200KB) 
输出:  BibTeX | EndNote (RIS)      
摘要 目的探讨钻孔尿激酶注入引流联合阿托伐他汀钙对慢性硬膜下血肿的疗效及预后。 方法收集我院自2014年1月~2016年12月收治的慢性硬膜下血肿患者230例,随机分为研究组和对照组,每组各115例。对照组患者给予单纯钻孔引流治疗, 研究组给予钻孔尿激酶注入引流联合阿托伐他汀钙口服治疗, 观察两组患者的疗效、 血肿复发及并发症情况, 以及患者的住院时间及住院费用。结果研究组患者的总有效率是96.65%,优于对照组患者的总有效率(84.35%)。研究组患者血肿复发率、 总并发症发生率、 住院费用及住院时间均低于对照组, 差异均有统计学意义(P<0.01)。结论利用钻孔尿激酶注入引流联合阿托伐他汀钙口服治疗慢性硬膜下血肿,效果明显优于单纯钻孔引流治疗,使血肿复发率和术后并发症发生率明显降低,并缩短患者的住院时间,从而降低住院费用,值得临床推广应用。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
ZHANG Lei1
HOU Meiying2
CHENG Gang3
GUO Yimin1
关键词:  血肿,硬膜下  引流术  尿激酶  阿托伐他汀钙    
Abstract: ObjectiveTo investigate the efficacy and prognosis of urokinase injection following punch drainage combined with oral atorvastatin calcium in the treatment of chronic subdural hematoma.MethodsFrom January 2014 to December 2016, a total of 230 patients with chronic dural hematoma were enrolled in this study, and were randomly divided into the study group and the control group, with 115 cases in each. The patients in the control group were treated with drilling and drainage only. And the study group was given urokinase injection following punch drainage combined with oral atorvastatin calcium. The curative effect, hematoma recurrence, complications, hospitalization time and the hospital costs were observed between the two groups.ResultsThe total effective rate was 96.65% in the study group and was better than 84.35% of the control group. The hematoma recurrence rate, the total complication rate, hospitalization time and hospitalization cost were lower in the study group than that of the control group (P<0.01).ConclusionIt is effective and safe of the urokinase injection following punch drainage combined with oral atorvastatin calcium for the treatment of chronic subdural hematoma, with the advantages of less hematoma recurrences, less complications, less hospitalization time and less hospitalization costs. It is worthy of clinical application and promotion.
Key words:  hematoma, subdural    drainage    urokinase    atorvastatin calcium
               出版日期:  2017-10-26      发布日期:  2018-05-25      期的出版日期:  2017-10-26
ZTFLH:  R651  
基金资助: 衡水市科技计划项目(编号: 2016014080Z)
作者简介:  张蕾,男,37岁,河北省衡水市第二人民医院神经外科主治医师。
引用本文:    
张蕾1,侯梅英2,程刚3,国义民1. 钻孔尿激酶注入引流联合阿托伐他汀钙治疗慢性硬膜下血肿的临床研究[J]. 中国现代手术学杂志, 2017, 21(5): 398-400,0.
ZHANG Lei1, HOU Meiying2, CHENG Gang3, GUO Yimin1. Clinical Research of Urokinase Injection Following Punch Drainage Combined with Oral Atorvastatin Calcium in the Treatment of Chronic Subdural Hematoma. Chinese Journal of Modern Operative Surgery, 2017, 21(5): 398-400,0.
链接本文:  
http://www.surgerychina.com/CN/10.16260/j.cnki.1009-2188.2017.05.018  或          http://www.surgerychina.com/CN/Y2017/V21/I5/398
[1] 呼其图, 刘和龙, 王永军. 92例慢性硬膜下血肿的治疗体会[J]. 中国临床神经外科杂志, 2017(3):193194.
[2] 刘碧明, 魏莱, 胡荣,等. 3种不同手术方式治疗慢性硬膜下血肿疗效观察[J]. 现代中西医结合杂志, 2017, 26(3):281283.
[3] Oh HJ, Lee KS, Shim JJ, et al. Postoperative course and recurrence of chronic subdural hematoma[J]. J Korean Neurosurg Soc, 2010,48(6):518523. doi: 10.3340/jkns.2010.48.6.518.
[4] Li Y, Zhang D, Zhang Y, et al. Augmentation of neovascularization in murine hindlimb ischemia by combined therapy with simvastatin and bone marrowderived mesenchymal stem cells transplantation[J]. J Biomed Sci, 2010 ,17:75. doi: 10.1186/142301271775.
[5] 张旭明, 伍卫. 辛伐他汀的临床应用与展望[J]. 中国药学杂志,2000,35(1):58.
[6] 刘建军, 刘海超, 王崇智. 辛伐他汀联合尼莫地平防治蛛网膜下腔出血后脑血管痉挛、迟发性脑缺血的作用[J].中国实用神经疾病杂志,2014,17(6):7677.
[7] 袁盾, 赵杰, 刘劲芳, 等. 417例慢性硬膜下血肿患者的临床特点分析[J]. 中南大学学报(医学版),2013,38(5):517520.
[8] 王慧晓, 沈益金, 陆洲, 等. 神经内镜手术治疗慢性硬膜下血肿[J]. 中华神经外科杂志,2013,29(7):684686.
[9] 李娟. 影像设备引导下立体定向血肿抽吸手术时机对高血压脑出血患者治疗效果的影响[J]. 中国现代手术学杂志,2015,19(4):309311.doi:10.16260/j.cnki.10092188.2015.04.019.
[10] 李伟华, 徐长庆, 李聪. 阿托伐他汀钙联合小剂量尿激酶治疗急性脑梗死的临床效果[J]. 中国生化药物杂志, 2016(5):183185.
[11] 杨舟山, 蔡恩源. 单纯钻孔引流法与钻孔尿激酶注入引流法治疗慢性硬膜下血肿的效果比较[J]. 中国处方药, 2015(1):106106.
[12] 胡方进, 陈爱珍, 沈东炜,等. 锥颅外引流术联合尿激酶灌洗治疗慢性硬膜下血肿[J]. 中国临床神经外科杂志, 2017(4):246247.
[1] 牟泳霖, 张筠, 曹军英, 里子彧, 于馨, 高越. PTGD治疗老年急性胆囊炎105例[J]. 中国现代手术学杂志, 2017, 21(6): 416-418.
[2] 洪文,刘扬,杨博,张忠伟,路明. 三间隙引流术治疗肛周脓肿临床疗效观察[J]. 中国现代手术学杂志, 2017, 21(4): 265-268.
No Suggested Reading articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed